JUL 16, 2019 3:18 AM PDT

Rare Bone Marrow Manifestation in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease with the hallmark diagnostic feature being non-caseating granulomas--clumps of immune cells including macrophages, epithelial cells, and histiocytes. While 90% of people diagnosed with sarcoidosis have it in their lungs, the disease can affect any organ system in the body. Common extrapulmonary sites include skin, liver, eyes, and lymph nodes. The incidence in the U.S. is approximately is 10 per 100,000 people. The principal investigator, J. Isaac Peña-Garcia, and colleagues, discuss a case study involving a rare manifestation of sarcoidosis in the bone marrow. 

Bone marrow sarcoidosis (BMS) has not been described frequently in the literature. Peña-Garcia cites several studies that illustrate the wide variation in age, gender, and ethnicity, which is common in the involvement of other extrathoracic organs. In a prospective cohort study in which the participants were 95.8% Caucasian, 640 patients were followed over 40 years. None had bone marrow manifestations initially, and at follow up, only 0.3% had BMS. In contrast, in the  ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study, there were 640 patients, of which 44% were African Americans, and 3.9% had BMS. 

In this case study, Peña-Garcia describes a 51-year-old African American woman with a previous diagnosis of cutaneous sarcoidosis. She presented with bilateral knee and lower leg pain as well as paresthesias without neurological involvement. She also had a "low-grade fever, hyporexia with an unintentional 30-pound weight loss over two years, and chronic dry cough." Among the numerous tests performed, a peripheral blood smear showed leukocytopenia and decreased red blood cells. The bone marrow biopsy showed normal cell lineage and non-caseating granulomas consistent with sarcoidosis.

The authors created an algorithm to follow when sarcoidosis patients present with decreased white blood cells and anemia:

Figure 1. A proposed approach to patient with sarcoidosis presenting with cytopenias. Credit  Peña-Garcia et al.

There have been no RCTs that compare different treatments, and to date, no FDA-approved treatment strategies for BMS, but prednisone is the gold standard for treatment of other forms of sarcoidosis. Methotrexate, which is used as a steroid-sparing medication, cannot be used in BMS due to its cytotoxic properties.

 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 08, 2021
Earth & The Environment
The Invasive Species Coming for your Wine!
SEP 08, 2021
The Invasive Species Coming for your Wine!
Invasive species are a problem throughout the world. Globalization means that we are continuously accidentally introduci ...
SEP 12, 2021
Cell & Molecular Biology
What Happens When Two Viruses Infect the Same Cell?
SEP 12, 2021
What Happens When Two Viruses Infect the Same Cell?
Pathgenic microbes that infect cells can affect each other. It's not unusual for people with viral respiratory infection ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
SEP 23, 2021
Technology
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
SEP 23, 2021
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around ...
Loading Comments...